Sialyl Lewis

aberrant glycosylation cytokeratin expression disease-free survival rate intermediate filament proteins sialyl LewisX/A (sLeX/A) triple-negative breast cancer (TNBC) α6 integrin

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
25 Jan 2023
Historique:
received: 24 11 2022
revised: 31 12 2022
accepted: 23 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 12 2 2023
Statut: epublish

Résumé

Triple-negative breast cancer (TNBC) encompasses multiple entities and is generally highly aggressive and metastatic. We aimed to determine the clinical and biological relevance of Sialyl-Lewis X and A (sLe

Identifiants

pubmed: 36765690
pii: cancers15030731
doi: 10.3390/cancers15030731
pmc: PMC9913872
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Fundação para a Ciência e Tecnologia
ID : UIDP/04378/2020
Organisme : Fundação para a Ciência e Tecnologia
ID : UIDB/04378/2020
Organisme : Fundação para a Ciência e Tecnologia
ID : LA/P/0140/202
Organisme : Fundação para a Ciência e Tecnologia
ID : SFRH/BD/100970/2014
Organisme : Fundação para a Ciência e Tecnologia
ID : SFRH/BD/138647/2018
Organisme : Fundação para a Ciência e Tecnologia
ID : SFRH/BD/148480/2019
Organisme : Fundação para a Ciência e Tecnologia
ID : 2020.09880.BD
Organisme : Liga Portuguesa Contra o Cancro
ID : LPCC/Pfizer2011
Organisme : GlycoCan Marie Curie Actions
ID : 676421
Organisme : Tagus Tank CUF-NOVA Medical School
ID : 2018

Références

J Immunol. 2018 Aug 1;201(3):1030-1043
pubmed: 29941663
Int J Cancer. 1997 Jun 20;74(3):296-300
pubmed: 9221808
Oncogene. 2022 Jul;41(30):3804-3820
pubmed: 35773413
Mod Pathol. 2006 Feb;19(2):264-71
pubmed: 16341146
Annu Rev Pathol. 2018 Jan 24;13:395-412
pubmed: 29414248
BMC Clin Pathol. 2012 Sep 26;12:18
pubmed: 23009686
Oncogene. 2020 Mar;39(12):2478-2492
pubmed: 31988452
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4429-34
pubmed: 17671126
Biochim Biophys Acta Gen Subj. 2018 Sep;1862(9):2069-2080
pubmed: 29777742
Jpn J Clin Oncol. 1997 Jun;27(3):135-9
pubmed: 9255266
Acta Clin Croat. 2016 Mar;55(1):3-8
pubmed: 27333711
Onco Targets Ther. 2017 Nov 20;10:5491-5524
pubmed: 29200866
Breast Cancer Res Treat. 2019 Aug;176(3):545-556
pubmed: 31054033
Ann Oncol. 2015 Sep;26 Suppl 5:v8-30
pubmed: 26314782
Int J Oncol. 2019 Nov;55(5):1033-1048
pubmed: 31793656
Indian J Pathol Microbiol. 2010 Oct-Dec;53(4):676-80
pubmed: 21045391
J Cell Biol. 1998 Apr 6;141(1):209-25
pubmed: 9531560
Cardiovasc Res. 2015 Aug 1;107(3):331-9
pubmed: 25994174
Theranostics. 2019 Oct 11;9(24):7431-7446
pubmed: 31695778
NPJ Breast Cancer. 2020 Oct 16;6:54
pubmed: 33088912
Cancer Res. 2011 Dec 15;71(24):7683-93
pubmed: 22025563
Mol Oncol. 2018 May;12(5):579-593
pubmed: 29215790
BMC Cancer. 2018 May 2;18(1):495
pubmed: 29716546
Oncogene. 2014 Apr 10;33(15):1934-44
pubmed: 23624916
Ther Adv Med Oncol. 2013 May;5(3):169-81
pubmed: 23634195
Clin Cancer Res. 2004 Aug 15;10(16):5367-74
pubmed: 15328174
Am J Pathol. 1996 Jan;148(1):165-75
pubmed: 8546203
Int J Surg Pathol. 2010 Jun;18(3):193-200
pubmed: 18611928
Front Oncol. 2021 Jun 16;11:681476
pubmed: 34221999
BMC Cancer. 2007 Jul 06;7:124
pubmed: 17617904
Physiol Rev. 1999 Jan;79(1):181-213
pubmed: 9922371
Breast Cancer (Auckl). 2021 Mar 22;15:11782234211002491
pubmed: 33814914
Clin Lung Cancer. 2013 Nov;14(6):704-12
pubmed: 23886796
Biology (Basel). 2017 Feb 23;6(1):
pubmed: 28241499
BMC Bioinformatics. 2018 May 4;19(1):168
pubmed: 29728051
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Cancers (Basel). 2022 Dec 27;15(1):
pubmed: 36612146
Front Immunol. 2018 Jan 19;8:1878
pubmed: 29403469
Molecules. 2021 Aug 27;26(17):
pubmed: 34500643
Med Oncol. 2014 Jan;31(1):801
pubmed: 24326984
Oncogene. 2009 Mar 5;28(9):1218-29
pubmed: 19151752
Immunity. 2007 Apr;26(4):477-489
pubmed: 17442598
Br J Pharmacol. 2019 Jan;176(1):82-92
pubmed: 29510460
Int J Cancer. 2006 Mar 1;118(5):1227-33
pubmed: 16152605
Breast Cancer Res Treat. 2009 Nov;118(1):131-7
pubmed: 19189211
Int J Mol Sci. 2020 Nov 05;21(21):
pubmed: 33167483

Auteurs

Carlota Pascoal (C)

UCIBIO, Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.
Associate Laboratory i4HB-Institute for Health and Bioeconomy, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.
CDG & Allies-Professionals and Patient Associations International Network (CDG & Allies-PPAIN), 2819-516 Caparica, Portugal.

Mylène A Carrascal (MA)

UCIBIO, Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.

Daniela F Barreira (DF)

UCIBIO, Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.
Associate Laboratory i4HB-Institute for Health and Bioeconomy, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.

Rita A Lourenço (RA)

UCIBIO, Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.
Associate Laboratory i4HB-Institute for Health and Bioeconomy, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.

Pedro Granjo (P)

UCIBIO, Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.
Associate Laboratory i4HB-Institute for Health and Bioeconomy, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.
CDG & Allies-Professionals and Patient Associations International Network (CDG & Allies-PPAIN), 2819-516 Caparica, Portugal.

Ana R Grosso (AR)

UCIBIO, Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.
Associate Laboratory i4HB-Institute for Health and Bioeconomy, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.

Paula Borralho (P)

Instituto de Anatomia Patológica, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.

Sofia Braga (S)

Unidade de Mama, Instituto CUF de Oncologia, 1998-018 Lisboa, Portugal.
NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1150-082 Lisbon, Portugal.

Paula A Videira (PA)

UCIBIO, Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.
Associate Laboratory i4HB-Institute for Health and Bioeconomy, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.
CDG & Allies-Professionals and Patient Associations International Network (CDG & Allies-PPAIN), 2819-516 Caparica, Portugal.

Classifications MeSH